Facilitating granule cell survival and maturation in dentate gyrus with baicalin for antidepressant therapeutics by Zhao, Fan et al.
Frontiers in Pharmacology | www.frontiers
Edited by:
Juan J. Canales,
University of Tasmania, Australia
Reviewed by:
Justin James Botterill,
Nathan Kline Institute for Psychiatric
Research, United States
Wladyslaw Lason,






This article was submitted to
Neuropharmacology,
a section of the journal
Frontiers in Pharmacology
Received: 07 May 2020
Accepted: 18 August 2020
Published: 02 September 2020
Citation:
Zhao F, Tao W, Shang Z, Zhang W,
Ruan J, Zhang C, Zhou L, Aiello H,
Lai H and Qu R (2020) Facilitating
Granule Cell Survival and Maturation in





published: 02 September 2020
doi: 10.3389/fphar.2020.556845Facilitating Granule Cell Survival
and Maturation in Dentate
Gyrus With Baicalin for
Antidepressant Therapeutics
Fan Zhao1, Weiwei Tao1, Zhiyuan Shang1, Weihua Zhang1, Jie Ruan1, Chenyiyu Zhang1,
Liping Zhou1, Hunter Aiello2, Hezheng Lai3,4 and Rong Qu1*
1 College of Chinese Medicine, College of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine,
Nanjing, China, 2 Independent Researcher, Boston, MA, United States, 3 Chinese Medicine Centre, Western Sydney University,
Campbelltown, NSW, Australia, 4 NICM Health Research Institute, Western Sydney University, Westmead, NSW, Australia
Baicalin isolated from Scutellaria baicalensis possesses antidepressant abilities through its
relation to hippocampal neurogenesis. Current research has found that baicalin can
promote the proliferation of hippocampal granule cells, however, the detailed mechanism
of baicalin on the survival and maturation of hippocampal granule cells has yet to be
sufficiently explored. The purpose of this study was to evaluate whether baicalin could
facilitate the survival and maturation of hippocampal granule cells, and to explore its
potential mechanism. The chronic corticosterone (CORT)-induced mouse model of
depression was used to assess antidepressant-like effects of baicalin and to illuminate
possible molecular mechanisms by which baicalin affects hippocampal neurogenesis. The
survival and maturation of granule cells were measured by immunohistochemistry,
immunofluorescence and Golgi staining. The expression of Phosphatidylinositol 3-
kinase (PI3K)/Protein kinase B (AKT)/glycogen synthase kinase-3b (GSK3b)/b-catenin
pathway related proteins were measured by western blot analysis. PI3K inhibitor
LY292002 and AKT inhibitor Perifosine were administered to HT-22 cells to explore the
relationship between the PI3K/AKT/GSK3b/b-catenin pathway and baicalin. The results of
the study illustrated that baicalin significantly decreased chronic CORT-induced
depressive-like behaviors and reduced serum corticosterone levels. In addition, baicalin
(administered at 60 mg/kg) reversed chronic CORT-induced lesions on hippocampal
granule cells. Moreover, baicalin significantly increased the phosphorylation rate of PI3K,
AKT, GSK3b, and total b-catenin. The study found that administration of LY292002/
Perifosine counteracted the effects of baicalin in HT-22 cells. These results demonstrate
that baicalin can alleviate chronic CORT-induced depressive-like behaviors through
promoting survival and maturation of adult-born hippocampal granule cells and
exhibiting protective effect on hippocampal neuron morphology. We propose the
underlying mechanisms involve the activation of the PI3K/AKT/GSK3b/b-
catenin pathway.
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Depression is considered one of the most burdensome diseases
globally, affecting approximately 264 million people worldwide
(GBD 2017 Disease and Injury Incidence and Prevalence
Collaborators, 2018). Major depressive disorder (MDD) is
associated with an increased suicide risk and poor quality of life
(Holden, 2005), accompanied by symptoms including: anhedonia,
irritability, depressed mood, difficulty in concentrating, and
abnormal appetite and sleep (Nakajima et al., 2010). Numerous
studies have demonstrated that hippocampal atrophy and
neurogenic damage in the adult hippocampus contribute to the
pathogenesis of depression (Stratmann et al., 2014; Fenton et al.,
2015; Kohman and Rhodes, 2017).
Recent studies show that corticosterone (CORT) levels are
upregulated during stress, and hippocampal neurogenesis is
inhibited by high CORT levels in primates (Bennett et al.,
2002; Coe et al., 2003). Long-term exposure to CORT can
induce depressive-like behaviors and cause neural deficits
in the hippocampus of rodents (Alfarez et al., 2009;
Morales-Medina et al., 2009), thus affecting neural progenitor
cell differentiation, neuron survival, migration, and synaptic
plasticity (Kunugi et al., 2010). Transgenic mice, with
proapoptotic gene Bax deleted from neural stem cells, exhibit
enhanced adult neurogenesis and resistance to depressive-like
behaviors induced by CORT (Hill et al., 2015). Depressive-like
behaviors induced by CORT can be improved by antidepressants
including escitalopram, amitriptyline and fluoxetine (Caldarone
et al., 2003; Furuse et al., 2019; Park, 2019). Antidepressants can
accelerate the maturation of newborn hippocampal cells and
promote their survival in animal models (Wang et al., 2008;Frontiers in Pharmacology | www.frontiersin.org 2Perera et al., 2011), resulting in decrease in depressive-like
behavioral symptoms.
The PI3K/AKT/GSK3b/b-catenin signaling pathway involved in
the survival and maturation of hippocampal granule cells plays an
important role for promoting antidepressant effects (Chen et al.,
2012;Matsudaet al., 2019).Activationof thePI3Kpathwaypromotes
PI3K-dependent phosphorylation and AKT phosphorylation.
Downstream, the subsequent promotion of GSK3 phosphorylation
inhibits GSK3 activity, thereby resulting in cytoplasm b-catenin
enrichment. Downregulation of GSK3b activity promotes the
stabilization and accumulation of b-catenin, increasing the
availability of b-catenin to be transported to the nucleus, where it
binds to transcription factors to upregulate transcription of
neurodevelopmental genes (Carol and Richard, 2001; Isabel and
Jeremy, 2001). Promotion of b-catenin enrichment facilitates the
survival and maturation of DG neurons, thereby combatting
depression and cognitive impairments, and contributing to
antidepressant activities (Xing et al., 2016; Hui et al., 2018).
Baicalin is a flavonoid isolated from the root of Scutellaria
baicalensis (Figure 1A), and commonly used for treatment of
depression in Chinese medicine. Previous studies have shown
that baicalin can improve depressive-like behaviors induced by
chronic unpredictable mild stress (CUMS), lipopolysaccharide
(LPS) and CORT, and promote the proliferation of adult
hippocampal granule cells (Zhang et al., 2016; Zhang et al.,
2018; Guo et al., 2019). Moreover, research indicates that
the PI3K/AKT signaling pathway is involved in baicalin’s
antidepressant effect in LPS-induced depressive-like behavior
in mice (Guo et al., 2019). Presently, the detailed mechanism
of baicalin on the survival and maturation of hippocampal
granule cells has yet to be sufficiently explored. The aim of thisA
B
FIGURE 1 | Chemical structure of baicalin and schematic representation of experimental groups and experimental procedures. (A) Chemical structural formula of
baicalin; (B) The schematic representation of the experimental procedure.September 2020 | Volume 11 | Article 556845
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survival and maturation of hippocampal granule cells and to
detail its potential mechanism.MATERIALS AND METHODS
Animals and Experimental Procedure
Fifty adult female C57BL/6J mice (6~8 weeks, weighing 18–22 g)
were purchased from the Shanghai Sipul-bikai Laboratory
Animal Limited Company, and maintained under standardized
environmental conditions consisting of: 12 h light/dark cycles
(lights on from 6:00 a.m. to 6:00 p.m.), a constant temperature
(22°C ± 2°C), food and water ad libitum, and five mice/cage.
Animals were habituated to the standard conditions for one
week, prior to experimental allocation and onset.
At baseline (week 0), mice were allocated into the following two
groups: 1) untreated control (n=10) and 2) CORT paradigm (n=40).
The procedure for establishing the mouse model of chronic CORT-
induced depression was performed as previously described (Zhang
et al., 2016). The 40 mice were subcutaneously injected daily for 6
weeks with CORT (40 mg/kg, TCI Development Co., Ltd, Japan)
dissolved in 0.9% saline containing 0.1% dimethyl sulfoxide
(DMSO). At the week-3 timepoint, CORT paradigm mice were
allocated into the following four treatment groups (n=10 per group):
CORT only, Escitalopram (ES, 10 mg/kg), Baicalin (BA 30 mg/kg),
and Baicalin (BA 60 mg/kg). Baicalin (BA 30 and 60 mg/kg) and
Escitalopram (ES, 10 mg/kg) were administered to mice in
respective corresponding groups starting on the 22nd day, on a
daily frequency, until the end of the experiment (week 6). Baicalin
(BA 30 and 60 mg/kg, Nanjing Liangwei Biotechnology Co., Ltd,
China, purity >98%) was dissolved in 0.9% saline and given to mice
daily by intragastric administration 30 min prior to the CORT
injection. Escitalopram (ES, 10 mg/kg, Sigma, USA) was similarly
dissolved in 0.9% saline and given to mice daily by intragastric
administration 30 min prior to the CORT injection (Figure 1B).
To facilitate the study of cell dynamics, injections of BrdU
(50 mg/kg/day, Sigma, USA) was administered intraperitoneally
to mice in all groups for 5 days, starting on the 22nd day,
following the procedure advised in a previous study (Gao et al.,
2018). Behavioral tests were performed at the end of the
experiment (week-6), with sucrose preference training (SPT)
also performed at baseline and week-3 timepoints, as it
necessitates. The average body weight of animals was recorded
for the six-week duration (see Supplementary Figure 1) and
despite considerable body weight loss, no animals experienced
mortality or were removed from the study due to CORT-related
complications. All animals were euthanized on the second day
following the behavioral tests’ completion. The experiment was
approved by the Animal Care Committee of Nanjing University
of Chinese Medicine. All efforts were made to minimize suffering
and to reduce the number of animals used.
Behavioral Tests
Five behavioral tests to assay anxiety- and depressive-like
behaviors were conducted. Video tracking was used to recordFrontiers in Pharmacology | www.frontiersin.org 3rodent behavior and to analyze the data. The behavioral tests
were conducted following the procedure advised in a previous
study (Zou et al., 2017) on days 42–44. The OFT and TST were
performed 1 h after the last administration of CORT on day 42.
The mice were then fasted (water and food) for 24 h. NFST was
performed on day 43. After completion of NFST, SPT was
performed, and mice were provided sufficient food and water.
FST was performed on day 44 after completion of SPT.
Sucrose Preference Test
Mice received sucrose preference training for a period of 24 h
upon which they received two bottles of sucrose solution (1%,
w/v); followed by 48 h of sucrose adaptation where one of the
bottles of sucrose solution was replaced with water, with bottle
positions exchanged at every 24-h interval. After the process of
sucrose adaptation, the mice were deprived of water for 24 h in
individual cages. Following this, the mice were given free access
to food and two bottles containing 100ml water and 100ml
sucrose solution (1%, w/v). After 24 h, the volumes of consumed
sucrose solution and water were recorded. Bottle positions
were exchanged carefully every 12 h. Sucrose preference was
calculated as percentage of the volume of sucrose solution
consumed over the total volume of water consumed over the
24 h of testing.
Open Field Test
Mice were individually placed in the center of an open field arena
(40 cm × 40 cm ×40 cm) and allowed to explore freely for 5 min.
The central area is defined as a square, sides 25 cm × 25 cm. A
camera was mounted above the open box to record locomotor
activity. The total distance traveled, and time spent in the central
area were recorded and analyzed by the tracking system
(DigBehavior, Shanghai, China).
Tail Suspension Test
Approximately 1 cm from the end, each mouse’s tail was taped
using adhesive tape, to a metal rod. Mice were suspended by the tail
approximately 50 cm from the floor. A camera was mounted in
front of the apparatus to record the movements of the mice for a
total of 6 min. The immobility time was automatically detected and
recorded with a tracking system during the last 4 min of the test.
Forced Swimming Test
Mice were individually placed in clean Plexiglas cylindrical tanks
(height 25 cm, diameter 10 cm) filled to a depth of 10 cm with
water (24°C ± 1°C) for 6 min. The movements of the mice were
tracked with a mounted camera and the immobility time of the
mice was recorded during the last 4 min of the test. Immobility
was defined as absence of all movement except motions required
to keep the mouse’s head above the water, as opposed to escape-
seeking or exploratory behaviors.
Novelty-Suppressed Feeding Test
The mice were transferred to the experimental environment after
fasting for 24 h. Each mouse was placed in the same corner of a
new cage to explore for 10 min with a weighed food pellet placed
in the center of the cage. The food consumption was recordedSeptember 2020 | Volume 11 | Article 556845
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food consumed/the weight of the mouse. The time the mice first
started to consume the food was recorded as the latency to feed.
Determination of Serum CORT Levels
Blood samples were collected after completion of the behavioral
tests. The amount of time elapse between the last CORT injection
and the measurement of serum CORT was approximately 55 h.
Serum CORT levels were measured using commercial enzyme-
linked immunosorbent assay (ELISA) kits in accordance with
manufacturer’s instructions (ZCIBIO, China). The serum CORT
of 10 mice per group was assayed, and the mean measurement
was calculated as the final score for the group.
Immunohistochemistry
Mice were anesthetized with sodium pentobarbital (50 mg/kg,
intraperitoneally) and were transcardially perfused (saline,
followed by 4% paraformaldehyde in PBS). Brains were
obtained and post-fixed overnight in 4% paraformaldehyde at
4°C, and then transferred to 20% and 40% sucrose solution.
Serial sections of 30 mm thickness were cut through the entire
hippocampus using a cryostat and stored in cryoprotectant (50%
glycerin in PBS). Every sixth coronal section from the adult
dentate gyrus was used to assess Ki67 and BrdU positive cells in
both hemispheres (10 sections per animal, 3 mice per group).
The sections were washed by PBS, then put into 3% hydrogen
peroxide for 15 min at room temperature. After three washes by
PBS, the sections were sealed by 10% BSA (0.3% triton-x100/
PBS) at room temperature for 1 h. The sealing fluid was
absorbed, and the sections were incubated for 24 h at 4°C with
primary antibody rabbit anti-Ki67(1:200, ab15580, Abcam) or
anti-BrdU (1:200, ab6326, Abcam). The tissues were washed in
PBS and then subsequently incubated with goat anti-rabbit hrp-
labeled secondary antibody (1:2000, ab205718, Abcam) for 40–
60 min at room temperature. DAB staining was applied to the
brain sections, color observation was made against white paper,
and the stain process was concluded within an appropriate time.
Ki67 and BrdU positive cells were observed and counted under
an Olympus BX63 microscope (Olympus, Tokyo, Japan) fitted
with a ×10 eyepiece lens with a ×40 objective.
Immunofluorescence
A triple-staining procedure was implemented for BrdU/DCX/
NeuN to allow analyzation through immunofluorescence. The
brain sections were incubated overnight at 4°C with the following
primary antibodies: rat anti-BrdU (1:200, ab6326, Abcam),
mouse anti-NeuN (1:500, ab104224, Abcam) and rabbit anti-
DCX (1:500, ab18723, Abcam). The sections were washed in PBS
and incubated for 4 h with fluorescent secondary antibodies:
Alexa Fluor 488 goat anti-rat IgG to reveal immunoreactivity of
BrdU, Alexa Fluor 405 donkey anti-mouse IgG to reveal
immunoreactivity of NeuN, and Alexa Fluor 594 goat anti-rabbit
IgG to reveal immunoreactivity of DCX, respectively (1:400 for all
three antibodies, Abcam). Every sixth coronal section from the
adult dentate gyrus was used to assess BrdU+/NeuN+/DCX- and
BrdU+/NeuN+/DCX+ positive cells in both hemispheres (10
sections per animal, 3 mice per group). BrdU+/NeuN+/DCX-Frontiers in Pharmacology | www.frontiersin.org 4and BrdU+/NeuN+/DCX+ positive cells were observed and
counted under an Olympus BX63 microscope fitted with a ×10
eyepiece lens with a ×40 objective, and their percent distribution in
the BrdU positive cells was calculated.
Golgi Staining
Golgi staining was performed according to the manufacturer’s
instructions (Hito Golgi-Cox OptimStainTM Kit, HTKNS1125,
Hitobiotec Corp., USA). Freshly dissected brains were immersed
in a mixture containing potassium dichromate and chromate at
25°C for 2 weeks and then transferred into Solution 3 according
to instruction kit protocol, where they rested at 4°C for 72 h in a
light-deprived area. Brain samples were then cut into 150-mm
sections and transferred to the gelatin-coated slides. Samples
were clarified with xylene and fixed with Neutral Balsam (Beijing
Solibao Technology Co. Ltd, China). Morphological analysis was
performed on pyramidal cells in accordance with the established
criteria (Li et al., 2004) using ImageJ 6.0 and an Olympus BX63
microscope (Olympus, Tokyo, Japan).
Cell Culture
The HT-22 cells were cultured in Dulbecco’s Modified Eagle
Medium (DMEM, Gibco) supplemented with 10% fetal bovine
serum (FBS, Biological Industries) and incubated at 37 °C in a
humidified incubator under 5% carbon dioxide. The cells were
pretreated with baicalin (30 mM), LY292002 (20 mM, HY-10108,
MCE) or Perifosine (40 mM, HY-60909, MCE) for 1 h followed
by post-incubation with CORT (600 mM) for 24 h, and cell
viability was measured by MTT assay.
Western Blot
The samples were lysed in a RIPA buffer containing protease
inhibitors and phosphatase inhibitors. The protein concentration
was determined by the BCA method (Pierce, Rockford, IL, USA),
and the protein cleavage product was separated by 10% SDS-PAGE
electrophoresis and transferred to a polyvinylidene fluoride (PVDF)
membrane. After blocking with 5% BSA for 1 h, the membrane was
incubated with a primary antibody at 4°C overnight. Primary
antibodies include PI3K (1:1,000, 11889, Cell Signaling), Phospho-
PI3K (1:1000,4228, Cell Signaling), AKT (1:500, 10176-2-A,
Proteintech), Phospho-AKT (1:500,66444-1-lg, Proteintech), GSK-
3b (1:1,000, 9315, Cell Signaling), Phospho-GSK-3b (Ser9) (1:1,000,
5558, Cell Signaling), b-catenin (1:1,000, ab32572, Abcam), PSD95
(1:1,000, 2507, Cell Signaling), Synaptophysin 1(1:1000,4329, Cell
Signaling). After incubation with the appropriate secondary
antibody for 1 h, the blot was visualized using SuperSignal West
Pico Chemiluminescent Substrate (Thermo Fisher Scientific Inc.).
The optical density was quantified by Image-J 6.0.
Statistical Analysis
According to the D’Agostino & Pearson or Shapiro–Wilk
normality test, our data exhibited a Gaussian distribution. T-
tests and one-way analysis of variance (ANOVA) followed by
Dunnett’s test were carried out using Graphpad 6.0, correcting
for multiple comparisons. T-tests were carried out to analyze the
results of SPT and body weight at the first three weeks, while one-
way ANOVA was used to determine the results of all the otherSeptember 2020 | Volume 11 | Article 556845
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SEM, with a P<0.05 considered statistically significant.RESULTS
Baicalin Decreases Chronic CORT-
Induced Depressive-Like Behaviors and
Serum CORT
The chronic CORT-induced depression model in mice was used
to study the antidepressant effects of baicalin (30, 60 mg/kg), and
its comparison to escitalopram (10 mg/kg). In the SPT
experiment, there was no difference at baseline in sucrose
consumption between the untreated control and CORT
paradigm group (t=0.02, P>0.05) (Figure 2A). At the week-3
time point, sucrose preference was significantly decreased in the
CORT paradigm group (t=3.98, P<0.01) (Figure 2A), indicating
that the CORT paradigm was successfully established. At the
week-6 timepoint, there was significant increase in sucrose
preference in both baicalin (60 mg/kg) and escitalopram (10
mg/kg) groups compared to the CORT only [F(4,45)=22.44,
P<0.01, Figure 2B], and sucrose preference in the baicalin (60
mg/kg) group was close to control (P>0.05). There was no
statistical difference between groups in total distance traveled
[F(4,45)=2.57, P>0.05, Figure 2C] and central time [F(4,45)=0.26,
P>0.05, Figure 2D] in the OFT experiment, indicating that
chronic CORT exposure did not affect autonomous activities.
In the TST and FST experiments, immobility time in the CORT
only group was significantly increased [F(4,45)=32.44, P<0.01,
Figure 2E; F(4,45)=20.4, P<0.01, Figure 2F], while immobility
time in the baicalin (30, 60 mg/kg) and escitalopram (10 mg/kg)
groups were significantly decreased compared to the CORT only
group (P<0.01), and immobility time of the baicalin (60 mg/kg) in
FST were close in range to the control group (P>0.05). In the
NSFT experiment, feeding latency was increased [F(4,45)=20.22,
P<0.01, Figure 2G] and food consumption was decreased [F
(4,45)=12.63, P<0.01, Figure 2H] in the CORT only group, while
the opposite was found in both baicalin (60 mg/kg) and
escitalopram (10 mg/kg) groups compared to CORT only
group (P<0.01; P<0.05, respectively). There was significant
reduction in food consumption across CORT+ES, CORT+BAL
and CORT+BAH groups compared to the control (P<0.01
respectively). The plasma CORT levels in the CORT only group
were significantly increased [F(4,45)=10.73, P<0.01, Figure 2I],
and were significantly decreased in the baicalin (30, 60 mg/kg)
and escitalopram (10 mg/kg) groups (P<0.01) compared to
CORT only group. The results of the behavioral studies indicate
the effectiveness of baicalin in improving chronic CORT-induced
depressive-like behaviors and reducing plasma CORT levels
in mice, with comparable results to the established
antidepressant escitalopram.
Baicalin Increases Proliferation and
Survival of Newborn Cells in DG
Immunohistochemistry was used to detect the effect of baicalin on
neurogenesis after chronic CORT exposure, with brain sectionsFrontiers in Pharmacology | www.frontiersin.org 5assessed by Ki67 tracking. The results showed a significant
reduction in neurogenesis after chronic exposure to CORT [F
(4,10)=66.92, P<0.01, Figures 3A, D], whereas treatment with
baicalin (30, 60 mg/kg) and escitalopram (10 mg/kg) significantly
increased the number of Ki-67 positive cells (P<0.01) compared to
CORT only. The enlarged Ki-67 positive cells are shown in Figure
3C. This suggests that baicalin canpromoteneurogenesis in chronic
CORT-induced depression model mice. Furthermore, as shown in
Figures 3B, F, the results of BrdU immunohistochemistry
indicated that newborn granule cells survival in DG was
significantly reduced after chronic exposure to CORT [F(4,10)
=93.76, P<0.01], while treatment with baicalin (30, 60 mg/kg) and
escitalopram (10 mg/kg) significantly increased cell survival
(P<0.05, P<0.01 and P<0.01respectively) compared to CORT
only. The enlarged BrdU positive cells are shown in Figure 3E.
Therewas significant reduction inKi-67 positive cells inCORT+ES,
CORT+BAL and CORT+BAH groups compared to the control
(P<0.05,P<0.01, andP<0.05 respectively), and significant reduction
in BrdU positive cells across the three treatment groups compared
to the control (P<0.01 respectively). The results suggest that
baicalin prevented CORT-induced changes in proliferation
and survival of newborn granule cells but did not normalize
the changes.
Baicalin Promotes Maturation of Newborn
Granule Cells in DG
To explore the effect of baicalin on the maturation of newborn
granule cells, triple-staining immunofluorescence of BrdU, DCX
and NeuN markers was analyzed (Figure 4A). The number of
BrdU+/DCX+/NeuN+(Figure 4B, yellow arrows) and BrdU+/
DCX-/NeuN+(Figure 4B, white arrows) positive cells decreased
after CORT exposure [F(4,10)=20.33, P<0.01, Figure 4C; F
(4,10)=47.53, P<0.01, Figure 4D], while cell numbers increased
after treatment with baicalin (60 mg/kg) and escitalopram (10
mg/kg) (P<0.01) compared with CORT only. BrdU+/DCX-/
NeuN+ positive cells in baicalin (60 mg/kg) and escitalopram
(10 mg/kg) were decreased compared to control group
respectively (P<0.05; P<0.01, respectively). In order to observe
the maturation of the BrdU cells in each group, the respective
ratios of the different cells tested were found and analyzed. The
results showed that the ratio of mature neurons decreased after
chronic CORT exposure [F(4,10)=14.11, P<0.01, Figure 4E],
while their ratios increased after the treatment of baicalin (60
mg/kg) and escitalopram (10 mg/kg) (P<0.05; P<0.01,
respectively) compared to CORT only. When combined, these
results show the positive influence of baicalin in promoting the
maturation of newborn granule cells.
Baicalin Enhances Dendritic Complexity of
Neuron Cells in DG
Golgi staining was used to detect the synaptic dendrite complexity,
spine density and the morphology of DG neurons (Figures 5A,
D). Following the experiment, the total dendritic length of DG
granule neurons were significantly reduced after chronic exposure
to CORT [F(4,40)=15.83, P<0.01, Figure 5B], while escitalopram
(10 mg/kg) and baicalin (60 mg/kg) treatment normalized thisSeptember 2020 | Volume 11 | Article 556845







FIGURE 2 | Effect of baicalin on different behaviors and serum corticosterone in corticosterone (CORT) induced depression model mice. (A) The basal sucrose
preference and the changes after three weeks of CORT paradigm; (B) The effect of baicalin on sucrose preference in CORT-induced depression model mice;
(C, D) Performance in the open field test; (E) Immobility time in the tail suspension test; (F) Immobility time in the forced swimming test; (G, H) Performance in
Novelty-suppressed feeding test; (I) The effect of baicalin in the changes of serum corticosterone. Data is expressed as mean ± SEM (n=10 mice/group). #P < 0 .05
and ##P < 0.01 versus Control, *P < 0.05 and **P < 0.01 versus CORT.Frontiers in Pharmacology | www.frontiersin.org September 2020 | Volume 11 | Article 5568456
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significantly reduce the total intersections of the DG granule
neurons [F60(4,40)=5.67, F80(4,40)=6.04, F100(4,40)=6.52, F120
(4,40)=10.54, F140(4,40)=11.15, F160(4,40)=13.04, F180(4,40)=4.94,
P<0.01, Figure 5C], while escitalopram (10 mg/kg) and baicalin
(60 mg/kg) can increased the total intersections compared to the
CORT only, especially at the distance of 140–160 mm (P<0.01 for
140 mm; P<0.01, P<0.05 respectively for 160 mm). Spine density
and mushroom spine density, measured at a distance of 100–160
mm from the soma in DG neurons, was unaltered by chronic
exposure to CORT, and similarly unaltered following baicalin
treatment [F(4,145)=2.02, P>0.05, Figure 5E; F(4,145)=0.55,
P>0.05, Figure 5F]. The results indicate that chronic CORT
exposure induced dendritic atrophy without impacting spine
density and mushroom spine density, while baicalin treatment
normalized the structural change caused by chronic CORT-
exposure, and similarly did not impact spine density and
mushroom spine density in granule cells.
Baicalin Attenuates the Depressive-Like
Behaviors Through Activation of PI3K/
AKT/GSK 3b/b-Catenin Pathway
To investigate whether the PI3K/AKT/GSK3b/b-catenin
pathway was involved in the antidepressant effect of baicalin,Frontiers in Pharmacology | www.frontiersin.org 7western blot analysis was performed to assess the expression of
related proteins in the hippocampus. We found that the p-PI3K,
p-AKT, p-GSK3b, and b-catenin protein expression levels were
significantly decreased after CORT exposure [F(4,10)=7.23, F
(4,10)=16.28, F(4,10)=8.49, F(4,10)=8.81, P<0.01, Figures 6A–
E], and these changes were normalized after escitalopram (10
mg/kg) and baicalin (60 mg/kg) treatment (P<0.01 for p-PI3K
and p-AKT; P<0.01, P<0.05 for p-GSK3b and b-catenin)
compared to CORT only. Next, protein expression levels of
synaptic proteins PSD95 and Syn in the hippocampus were
analyzed. As shown in Figures 6F–H, the total PSD95 and Syn
expression were significantly decreased in mice after chronic
CORT exposure [F(4,10)=7.12, F(4,10)=12.55, P<0.01, Figures
6G, H], while these levels were significantly increased after
treatment with escitalopram (10 mg/kg) and baicalin (60 mg/
kg) (P<0.05 for PSD95; P<0.05, P<0.01 respectively for Syn)
compared to CORT only.
In vitro, HT-22 cells were pretreated by baicalin for 1 h. Cell
viability was determined by MTT assay. The drug concentration
for the best CORT model of HT-22 cells was 600uM [F
(7,16)=52.96, P<0.001, Figure 7A], while the optimal
concentration of baicalin, LY294002 and Perifosine was 30 mM,
20 mM, and 40 mM respectively [F(9,20)=32.06, F(4,10)=26.26,






FIGURE 3 | Baicalin treatment increased proliferation and survival of newborn granule cells in the dentate gyrus of chronic corticosterone (CORT)-induced
depression model mice. (A) Images of Ki-67 immunohistochemistry in DG granular neurons; (B) Images of BrdU immunohistochemistry in DG granular neurons;
(C) Enlarged image of the Ki-67 cells; (D) The total number changes of Ki-67 cells; (E) Enlarged image of the BrdU cells; (F) The total number changes of BrdU cells.
The results are mean ± SEM (n=3 mice/group), scale bar=50 mm. #P < 0 .05 and ##P < 0.01 versus Control, *P < 0.05 and **P < 0.01 versus CORT.September 2020 | Volume 11 | Article 556845





FIGURE 4 | Baicalin promotes maturation of newborn granule cells in the dentate gyrus of chronic corticosterone (CORT)-induced depression model mice.
(A) Hippocampal dentate gyrus (DG) images of the adult newborn neurons (red: DCX; green: BrdU; Blue: NeuN), scale bar=50 mm; (B) Enlarged images of the
newborn immature neurons (morphology of DCX+/NeuN+/BrdU+ cells, yellow arrows) and the mature neurons (morphology of DCX-/NeuN+/BrdU+ cells, white
arrows), scale bar=20 mm; (C) The number of the newborn immature neurons; (D) The number of adult born mature neurons; (E) The proportion of DCX-/NeuN
+/BrdU+ cells (percentage of BrdU cells). The results are mean ± SEM (n=3 mice/group). #P < 0 .05 and ##P < 0.01 versus Control, *P<0.05 and **P<0.01 versus
CORT.Frontiers in Pharmacology | www.frontiersin.org September 2020 | Volume 11 | Article 5568458





FIGURE 5 | Baicalin enhances dendritic complexity without affecting spine density of granule cells in the dentate gyrus of chronic corticosterone (CORT)-induced
depression model mice. (A) Dendritic arbors measured by Golgi staining and reconstruction of the dendritic arbors in DG granular neurons, scale bar=50 mm;
(B) Sholl analyses of total dendritic length in DG granule neurons; (C) Sholl analyses of the numbers of dendritic points in DG granule neurons; (D) Representative
graphs of dendritic spines in hippocampal DG granule neurons, scale bar =10 mm; (E) The density of the total spines; (F) The density of the mushroom-shaped
spines. Data is represented as means ± SEM (n=3 mice/group, (B, C) 3 neurons were analyzed for each animal; (E, F) 10 neurons were analyzed for each animal).
##P < 0.01 versus Control, *P < 0.05 and **P < 0.01 versus CORT.Frontiers in Pharmacology | www.frontiersin.org September 2020 | Volume 11 | Article 5568459
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were significantly decreased [F(4,10)=18.48, F(4,10)=18.40, F
(4,10)=11.59, F(4,10)=7.90, P<0.01, Figures 7D–H] compared to
control, and were significantly up-regulated by baicalin treatment
(P<0.01 for p-PI3K and p-AKT; P<0.05 for p-GSK3b and b-Frontiers in Pharmacology | www.frontiersin.org 10catenin) compared to CORT only. Interestingly, the effect of
baicalin was counteracted in the LY294002 and Perifosine
treated groups (P>0.05) compared to CORT only. These results
suggest that baicalin may improve depressive-like behaviors





FIGURE 6 | PI3K/AKT/GSK3b/b-catenin pathway is involved in the antidepressant effect of baicalin. (A) Representative western blots of PI3K/AKT/GSK3b/b-catenin pathway
relative protein expression; (B–E) The quantification of p-PI3K, p-AKT, p-GSK-3b (Ser9) and b-catenin protein expression in hippocampus; (F) Representative western blots of
PSD95 and Synaptophysin1 protein expression in hippocampus; (G, H) The quantification of PSD95 and Synaptophysin1 protein expression in hippocampus. Data are
represented as means ± SEM (n=3 mice/group). #P < 0 .05 and ##P < 0.01 versus Control, *P < 0.05 and **P < 0.01 versus CORT.September 2020 | Volume 11 | Article 556845





FIGURE 7 | LY294002 and Perifosine blocked the effect of baicalin in HT-22 cells induced by corticosterone (CORT). (A) The effect of corticosterone induced cell
viability loss in HT-22 cells; (B) Baicalin alleviates corticosterone-induced cell viability loss in HT-22 cells; (C) PI3K inhibitor LY294002 and AKT inhibitor Perifosine
blocked the effect of baicalin; (D) Representative western blots of PI3K/AKT/GSK3b/b-catenin pathway relative protein expression; (E–H) The quantification of
p-PI3K, p-AKT, p-GSK-3b (Ser9), and b-catenin protein expression in CORT-induced HT-22 cells. Data are represented as means ± SEM (Each result based on
three times experiment). #P < 0 .05 and ##P < 0.01 versus Control, *P < 0.05 and **P < 0.01 versus CORT, &P < 0.05 and &&P < 0.01 versus CORT+BA.Frontiers in Pharmacology | www.frontiersin.org September 2020 | Volume 11 | Article 55684511
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Numerous studies have illustrated baicalin’s neuroprotective
abilities in central nervous system diseases (Zhang et al., 2016;
Gao et al., 2018; Sowndhararajan et al., 2018; Zhang et al., 2018;
Guo et al., 2019; Jin et al., 2019). In addition, prior studies have
demonstrated that baicalin has antidepressant effects and can
reduce neuroinflammation (Guo et al., 2019; Jin et al., 2019),
protect neuron apoptosis (Zhang et al., 2018) and promote adult
hippocampal neurogenesis in animal models of depression
(Gao et al., 2018). Although current research indicates that
baicalin can promote the proliferation of hippocampal granule
cells, the mechanism of baicalin on the survival and maturation
of hippocampal granule cells has yet to be sufficiently detailed.
Corresponding to prior literature, the chronic CORT
administration used in the present study established a
preclinical model of depression, through the induction of
behavioral and neurological changes that are consistent in
patients with depression (Zhao et al., 2009; Sterner and
Kalynchuk, 2010; Rainer et al., 2012). In this study, following 6
weeks of subcutaneous injection of CORT, mice exhibited
significant behavioral alterations including: decreased sucrose
preference, increased immobility time in FST and TST, increased
latency and decreased food intake in NFST, and increased serum
CORT level. These results are indicative that subcutaneous
injections of CORT induce depressive-like behaviors in female
mice. Complementing previous studies of baicalin’s ability to
decrease chronic CORT-induced depressive-like behaviors in
male mice (Li et al., 2015; Gao et al., 2018), this study found
that baicalin has the same capabilities for female mice under the
same preclinical model of depression, thus enhancing the
evidence of baicalin’s potential for antidepressant effects.
Recently, the correlation between granule cell proliferation and
their antidepressant effects have been documented (Park, 2019).
Increased neurogenesis achieved by improving the survival rate and
maturation of newborn neurons can decrease depressive-like
behaviors (Sterner and Kalynchuk, 2010; Anacker et al., 2018).
While previous studies have found that baicalin could increase the
proliferation of adult granule cells in animal models of depression
(Zhang et al., 2016; Gao et al., 2018), its effect on the survival and
maturation of proliferated granule cells required further
investigation. In order to do this for the present study, BrdU
labeling was conducted at the start of baicalin administration.
Following its completion, it was found that after CORT exposure,
the number of Ki67 labeled proliferating cells was reduced, which is
consistent with previous research (Anacker et al., 2018), while the
effect was countered by baicalin treatment, as the number of Ki67
positive cells significantly increased, and were normalized closer to
the control. The number of BrdU cells in the DG was also
significantly increased after baicalin treatment, and it was shown
that baicalin facilitated the maturation of newborn granule cells and
increased the number of BrdU+/NeuN+/DCX− neurons. The
evidence of these results reinforces baicalin’s abilities in
promoting the survival and maturation of granule cells.
xChanges in hippocampal neuron morphology after baicalin
treatment were assessed in this study. Previous studies showedFrontiers in Pharmacology | www.frontiersin.org 12that chronic CORT exposure caused decreased neurogenesis and
impaired dendrite morphology in DG and CA regions, and
depression-related behavioral symptoms (Watanabe et al.,
1992; Kim and Diamond, 2002; Bechstedt et al., 2014). Studies
have also found that dendritic structure and complexity in the
basal dendrites of CA3 pyramidal neurons was reduced
by postpartum CORT administration (Sousa et al., 2000;
Workman et al., 2013). Consistent to prior findings, this study
illustrated that the six-week CORT paradigm induced dendritic
atrophy without affecting spinal density in granule cells and
found that baicalin significantly improved the dendritic
complexity of granule cells and without altering the
morphology of the mushroom spines of basal dendrites in
DG. Moreover, CORT-induced downregulation in protein
expressions of the presynaptic marker (synaptophysin1) and
the postsynaptic marker (PSD95) was blocked following
baicalin treatment. These results suggest that baicalin may also
play a protective role in hippocampal neuron morphology.
Recent studies of mice models of depression have indicated that
changes in synaptic plasticity, learning, memory, and depression are
related to issues in the PI3K signaling pathway (Matsuda et al., 2019).
Activation of PI3K pathway promotes both AKT and subsequent
GSK3b phosphorylation, which then inhibits the latter’s activity.
Downregulation of GSK3b through its inhibition and/or decreased
activity promotes the stabilization and accumulation of available
cytoplasmic, and ultimately nucleic b-catenin, where it can regulate
and promote neurodevelopmental genes. Therefore, decreased
GSK3b activity and subsequent b-catenin enrichment aids in the
promotion of efficient formation of microtubules throughout the
neurite, resulting in more branching and synaptic connections in
adult-born granular neurons (Garrido et al., 2007; Llorens-Martin
et al., 2016). b-catenin, the main substrate of GSK3b, has been
identified as a key regulator of depressive-like behaviors (Madsen
et al., 2003; Dias et al., 2014), and increased GSK3b activity was
correlated with decreased levels of b-catenin in the prefrontal cortex
of depressed patients (Karege et al., 2012). Our previous experiments
showed that baicalin increased the expression of phosphorylated
GSK3b (Ser9) protein and activation of PI3K/AKT pathway in the
hippocampus of CUMS model animals (Zhang et al., 2018; Guo
et al., 2019). The current data showed that chronic CORT exposure
reduces the expression of phosphorylated PI3K, AKT, GSK3b (Ser9)
proteins and total b-catenin protein, while baicalin treatment could
counter CORT effects. To confirm the crucial role of baicalin-
regulated PI3K/AKT/GSK3b/b-catenin pathway in regulating
hippocampal granule cells, inhibitor validation treatment was
performed on the hippocampal neurons of HT-22 cells. We found
that the effect of baicalin on CORT-induced HT-22 cells was
counteracted by PI3K and AKT inhibitor. These results suggest
that baicalin and CORT produce opposing effects on adult-born
hippocampal granule cells, particularly through baicalin’s activation
of the PI3K/AKT/GSK3b/b-catenin pathway. Hence, baicalin may
combat depression and depression-related cognitive impairments by
facilitating survival and maturation of DG neurons through
upregulation of b-catenin enrichment.
In conclusion, this study demonstrated that baicalin effectively
alleviated chronic CORT induced depressive-like behaviors in miceSeptember 2020 | Volume 11 | Article 556845
Zhao et al. Antidepressant Effects of Baicalinand promoted hippocampal neurogenesis. The effect of baicalin
may be attributed to its ability to promote survival and maturation
of adult-born hippocampal granule cells, and its protective effect on
hippocampal neuron morphology. The underlying mechanisms
involve baicalin’s related activation of the PI3K/AKT/GSK3b/b-
catenin pathway (Figure 8): its counteractive abilities on CORT,
and its promotion of the PI3K/AKT enzymatic signaling pathway
proteins, including enrichment of neurodevelopment transcription
regulator b-catenin. These results support the interest of baicalin-
based therapeutic strategies, and to further the development of
complementary medicines for treating depression.DATA AVAILABILITY STATEMENT
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